drugset / Trial / NCT00956319

A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients

NCT00956319

Phase 4 Completed 42 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the efficacy and safety of zolpidem modified release (MR) tablet using estazolam (Eurodin) as a comparative drug in patients with primary insomnia.

Timeline

Start
2009-05
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estazolam Small molecule Oral
Subject Zolpidem Small molecule Oral